0.84595
0.02205 (2.68%)
0.02205 (2.68%)
Upgrade to Real-Time
Market Open
Low
0.1285
High
1.09
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MariMed Inc (QX) | MRMD | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.02205 | 2.68% | 0.84595 | 15:08:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.82 | 0.82 | 0.87 | 0.8239 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.84 | 0.857 | 0.017 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 589 | 1,390,043 | $ 0.851847 | $ 1,184,104 | - | 0.1285 - 1.09 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:08:44 | 1,000 | $ 0.84595 | USD |
MariMed (QX) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 118.39M | 139.66M | 119.12M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 579.74k | $ - | - | - | - |
MariMed (QX) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.77 | 0.87 | 0.715 | 0.7770038 | 734,370 | 0.07595 | 9.86% |
| 1 Month | 0.654 | 0.87 | 0.601 | 0.7381806 | 720,955 | 0.19195 | 29.35% |
| 3 Months | 0.81 | 0.928 | 0.6001 | 0.7579298 | 861,268 | 0.03595 | 4.44% |
| 6 Months | 0.19 | 1.09 | 0.16 | 0.6048928 | 2,160,480 | 0.65595 | 345.24% |
| 1 Year | 0.144 | 1.09 | 0.1285 | 0.4167476 | 1,880,631 | 0.70195 | 487.47% |
| 3 Years | 1.92 | 5.80 | 0.10 | 0.9881019 | 977,692 | -1.07 | -55.94% |
| 5 Years | 0.14 | 5.80 | 0.0553 | 0.9809164 | 646,281 | 0.70595 | 504.25% |
MariMed (QX) Description
| MariMed, a multi-state cannabis operator, is dedicated to improving the health and wellness of people through the use of cannabinoids and cannabis products. The Company develops, owns and manages seed to sale state licensed cannabis facilities which are models of excellence in horticultural principles, cannabis cultivation, cannabis infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. MariMed is at the forefront of science and innovation through research developed by its lab technicians and medical advisors resulting in industry leading products and brands, including "Kalm Fusion" and "Betty's Eddies". These precision dosed products are focused on specific medical symptoms resulting effects which are licensed and distributed across the country. In 2019, with the passing of the 2019 US Farm Bill, MariMed formed MariMed Hemp a wholly owned subsidiary to leverage its seed to sale cannabis platform and experience into the emerging CBD industry. The Company acquired a significant stake in Kentucky based, GenCanna Global, a national and international leading cultivator, producer, and distributer of hemp and GMP quality CBD oils and isolates. With this strategic relationship MariMed Hemp has developed and is marketing its new portfolio CBD brands and products to multiple retailers and direct to consumers both domestically and internationally. The Company recently launched its "Hemp Engine" "store within a store" distribution platform for retailers. MariMed Hemp is actively pursuing other hemp industry business opportunities with genetics, farming, biomass, and new and innovative technologies. |
